Lantheus Holdings, Inc. Proceeds from (Payments for) Other Financing Activities
Lantheus Holdings, Inc. (LNTH) reported Proceeds from (Payments for) Other Financing Activities of -$74.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2017-11-02
- Lantheus Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2017-06-30 was $0.00.
- Lantheus Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2017-03-31 was -$74.00K.
- Lantheus Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2016-09-30 was $11.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | -$74.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$74.00K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | -$74.00K 10-Q · filed 2017-05-02 | ||
| 2016-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $11.00K derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$11.00K 10-Q · filed 2017-08-01 | |
| 2016-03-31 | -$11.00K 10-Q · filed 2017-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |